Forget SCHD: This Monthly Dividend Grower Beat It by 38%
A monthly dividend growth fund has outperformed SCHD by 38 percentage points over the past decade, challenging the tr...
Which Altcoins Have Strong Tech And Low Market Cap
Which Altcoins Have Strong Tech And Low Market Cap combines advanced tech with room to grow. This intro guides evaluation of core tech, roadmap, and market activity.
28,400 articles
Tesla Delivered 480,126 Vehicles: Why the Stock Didn't Rally
Tesla pushed out a solid delivery quarter, but the stock didn’t follow. This article breaks down what the numbers mea...
Will Bitcoin Drop $50,000 as Strategy Sells BTC Moves?
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
Better Artificial Intelligence (AI) Stock Buy: AMD vs Nvidia
June brings a pivotal AI stock showdown between AMD and Nvidia. This guide breaks down how to evaluate which offers b...
With Stock Down Roughly 60%: Should Nike Be a Buy?
Nike has faced a decades-long love-hate relationship with investors: the brand remains powerful, but the stock has sl...
Kimi WebBridge Lets Agents Drive Your Browser Locally
A new browser extension puts AI agents in the driver's seat without exposing your data. Learn how Kimi WebBridge Lets...
Beta's Sold 30,000 Company: What Investors Should Do
A CEO sold 30,000 shares and sparked questions about beta's future. This guide breaks down what insider sales really ...
Futu Stock Plunged Regulatory Sparks Investor Review Today
When regulatory headlines hit a fintech stock, prices can swing wildly. This article unpacks the futu stock plunged r...
Bitcoin ETF Outflows Reach 3-Month High of $635M in May
The bitcoin outflows just 3-month window intensified Friday, with a $635 million pull on May 13 led by BlackRock’s IB...
Upstart Plunged February: Key Drivers Behind the Selloff
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Anheuser-Busch Still Even Though People Drink Less—A Buy Case
Even as global drinking declines, Anheuser-Busch InBev shows resilience through a diversified brand mix, cost discipl...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status